London, UK: Merck, Agilent Technologies and SkyCell provide advice on the increasing complexity of globally transporting products in a new report from Pharma Logistics IQ.
In the report, Pharma Logistics IQ explores the benefits of using a hybrid container solution in cold-chain handling to maximise process efficiencies, fulfill a sudden rise in on demand deliveries and enhance pharma’s sustainable initiatives.
The report also dives into insights and real-life case studies from Merck, Agilent Technologies and SkyCell to help pharma companies improve their implementation strategies for hybrid containers.
